Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Alzheimer
Questions discussed in this category
When do you evaluate patients with Parkinson's disease and cognitive decline for concurrent Alzheimer's disease?
Are such patients candidates for anti-amyloid therapy?
1 Answer available
22944
Papers discussed in this category
Ann Neurol, 2021 Jan
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
Related Topics
Neurology
Behavioral Neurology & Neuropsychiatry
Movement disorders
